Investigation of the human FCRL1, 2, and 4 gene expressions in patients with rheumatoid arthritis

Rheumatology International

Volumn 36, Issue 8, 2016, Pages 1149-1156

  Khanzadeh, Ali ^a   Habibagahi, Zahra ^a   Hosseini, Ahmad ^b   Amirghofran, Zahra ^a,c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Fc receptor like molecules; mRNA; Real time PCR; Rheumatoid arthritis

Indexed keywords

BIOLOGICAL MARKER; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; FC RECEPTOR; FC RECEPTOR LIKE 1; FC RECEPTOR LIKE 2; FC RECEPTOR LIKE 4; MESSENGER RNA; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; FCRL1 PROTEIN, HUMAN; FCRL2 PROTEIN, HUMAN; FCRL4 PROTEIN, HUMAN; MEMBRANE PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATIONAL STUDY; DAS28; DISEASE ASSOCIATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; GENE EXPRESSION; GENETICS; MIDDLE AGED; YOUNG ADULT;

ADULT; AGED; ARTHRITIS, RHEUMATOID; FEMALE; GENE EXPRESSION; HUMANS; MEMBRANE PROTEINS; MIDDLE AGED; RECEPTORS, CELL SURFACE; RECEPTORS, FC; YOUNG ADULT;

EID: 84969909559     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-016-3495-2     Document Type: Article

References (32)

1. Gibofsky A (2012) Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag Care 18(13 Suppl):S295–S302
2. Imboden JB (2009) The immunopathogenesis of rheumatoid arthritis. Annu Rev Pathol 4:417–434
3. Golmoghaddam H, Amirghofran Z, Aflaki E, Kamali-Sarvestani E, Shabani M, Esmaeilbeig M, Rajabi M (2013) Association of FCRL3 genotypes with susceptibility of Iranian patients to rheumatoid arthritis. Immunol Invest 42:296–306
4. Moura RA, Graca L, Fonseca JE (2012) To B or not to B the conductor of rheumatoid arthritis orchestra. Clin Rev Allergy Immunol 43:281–291
5. Díaz-González JF, Amaro IF (2007) The B cell in the pathogenesis of rheumatoid arthritis. Reumatol Clin 3:176–182
6. Tak PP, Rigby WF, Rubbert-Roth A, Peterfy CG, van Vollenhoven RF, Stohl W, Hessey E, Chen A, Tyrrell H, Shaw TM (2011) Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial. Ann Rheum Dis 70:39–46
7. Keystone E, Emery P, Peterfy CG, Tak PP, Cohen S, Genovese MC, Dougados M, Burmester GR, Greenwald M, Kvien TK, Williams S, Hagerty D, Cravets MW, Shaw T (2009) Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies. Ann Rheum Dis 68:216–221
8. Davis RS, Wang YH, Kubagawa H, Cooper MD (2001) Identification of a family of Fc receptor homologs with preferential B cell expression. Proc Natl Acad Sci U S A 14(98):9772–9777
9. Hatzivassiliou G, Miller I, Takizawa J, Palanisamy N, Rao PH, Iida S, Tagawa S, Taniwaki M, Russo J, Neri A, Cattoretti G, Clynes R, Mendelsohn C, Chaganti RS, Dalla-Favera R (2001) IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy. Immunity 14:277–289
10. Davis RS (2007) Fc receptor-like molecules. Annu Rev Immunol 25:525–560
11. Maltais LJ, Lovering RC, Taranin AV, Colonna M, Ravetch JV, Dalla-Favera R, Burrows PD, Cooper MD, Davis RS (2006) New nomenclature for Fc receptor-like molecules. Nat Immunol 7:431–432
12. Davis RS, Dennis G Jr, Odom MR, Gibson AW, Kimberly RP, Burrows PD, Cooper MD (2002) Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene family. Immunol Rev 190:123–136
13. Mechetina LV, Najakshin AM, Volkova OY, Guselnikov SV, Faizulin RZ, Alabyev BY, Chikaev NA, Vinogradova MS, Taranin AV (2002) FCRL, a novel member of the leukocyte Fc receptor family possesses unique structural features. Eur J Immunol 32:87–96
14. Masir N, Jones M, Pozzobon M, Marafioti T, Volkova OY, Mechetina LV, Hansmann ML, Natkunam Y, Taranin AV, Mason DY (2004) Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cells. Br J Haematol 127:335–343
15. Kazemi T, Asgarian-Omran H, Memarian A, Shabani M, Sharifian RA, Vossough P, Ansaripour B, Rabbani H, Shokri F (2009) Low representation of Fc receptor-like 1–5 molecules in leukemic cells from Iranian patients with acute lymphoblastic leukemia. Cancer Immunol Immunother 58:989–996
16. Kazemi T, Asgarian-Omran H, Hojjat-Farsangi M, Shabani M, Memarian A, Sharifian RA, Razavi SM, Jeddi-Tehrani M, Rabbani H, Shokri F (2008) Fc receptor-like 1–5 molecules are similarly expressed in progressive and indolent clinical subtypes of B-cell chronic lymphocytic leukemia. Int J Cancer 1:2113–2119
17. Wang K, Pei H, Huang B, Yang R-L, Wu H-Y, Zhu X, Zhu L (2012) Overexpression of Fc receptor-like 1 associated with B-cell activation during hepatitis B virus infection. Braz J Med Biol Res 45:1112–1118
18. Kochi Y, Yamada R, Suzuki A, Harley JB, Shirasawa S, Sawada T, Bae SC, Tokuhiro S, Chang X, Sekine A, Takahashi A, Tsunoda T, Ohnishi Y, Kaufman KM, Kang CP, Kang C, Otsubo S, Yumura W, Mimori A, Koike T, Nakamura Y, Sasazuki T, Yamamoto K (2005) A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet 37:478–485
19. Ikari K, Momohara S, Nakamura T, Hara M, Yamanaka H, Tomatsu T, Kamatani N (2006) Supportive evidence for a genetic association of the FCRL3 promoter polymorphism with rheumatoid arthritis. Ann Rheum Dis 65:671–673
20. Matesanz F, Fernández O, Milne RL, Fedetz M, Leyva L, Guerrero M, Delgado C, Lucas M, Izquierdo G, Alcina A (2008) The high producer variant of the Fc-receptor like-3 (FCRL3) gene is involved in protection against multiple sclerosis. J Neuroimmunol 195:146–150
21. Simmonds MJ, Heward JM, Carr-Smith J, Foxall H, Franklyn JA, Gough SC (2006) Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves’ disease. J Clin Endocrinol Metab 91:1056–1061
22. Ramírez-Bello J, Jiménez-Morales S, Espinosa-Rosales F, Gómez-Vera J, Gutiérrez A, Velázquez Cruz R, Baca V, Orozco L (2013) Juvenile rheumatoid arthritis and asthma, but not childhood-onset systemic lupus erythematosus are associated with FCRL3 polymorphisms in Mexicans. Mol Immunol 53:374–378
23. Leu C-M, Davis RS, Gartland LA, Fine WD, Cooper MD (2005) FcRH1: an activation coreceptor on human B cells. Blood 105:1121–1126
24. Ehrhardt GR, Davis RS, Hsu JT, Leu C-M, Ehrhardt A, Cooper MD (2003) The inhibitory potential of Fc receptor homolog 4 on memory B cells. Proc Natl Acad Sci U S A 100(23):13489–13494
25. Jackson TA, Haga CL, Ehrhardt GR, Davis RS, Cooper MD (2010) FcR-like 2 Inhibition of B cell receptor-mediated activation of B cells. J Immunol 185:7405–7412
26. Nückel H, Collins CH, Frey UH, Sellmann L, Dürig J, Siffert W, Dührsen U (2009) FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemia. Eur J Haematol 1:541–549
27. Baranov KO, Volkova OY, Mechetina L, Chikaev N, Reshetnikova E, Nikulina G, Taranin AV, Naiakshin AM (2012) Expression of human B-cell specific receptor FCRL1 in healthy individuals and in patients with autoimmune diseases. Mol Biol (Mosk) 46:500–507
28. Rostamzadeh D, Dabbaghmanesh MH, Shabani M, Hosseini A, Amirghofran Z (2015) Expression profile of human Fc receptor-Like 1, 2, and 4 molecules in peripheral blood mononuclear cells of patients with Hashimoto’s thyroiditis and Graves’ disease. Horm Metab Res 47:693–698
29. Yeo L, Lom H, Juarez M, Snow M, Buckley C, Filer A, Raza K, Scheel-Toellner D (2015) Expression of FcRL4 defines a pro-inflammatory, RANKL-producing B cell subset in rheumatoid arthritis. Annals of the rheumatic diseases. Ann Rheum Dis 74:928–935
30. Wei C, Anolik J, Cappione A, Zheng B, Pugh-Bernard A, Brooks J, Lee EH, Milner EC, Sanz I (2007) A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic Lupus Erythematosus. J Immunol 178:6624–6633
31. Moura RA, Weinmann P, Pereira PA, Caetano-Lopes J, Canhão H, Sousa E, Mourão AF, Rodrigues AM, Queiroz MV, Souto-Carneiro MM, Graça L, Fonseca JE (2010) Alterations on peripheral blood B-cell subpopulations in very early arthritis patients. Rheumatol (Oxford) 49:1082–1092
32. Michelutti A, Gremese E, Morassi F, Petricca L, Arena V, Tolusso B, Alivernini S, Peluso G, Bosello SL, Ferraccioli G (2011) B-cell subsets in the joint compartments of seropositive and seronegative rheumatoid arthritis (RA) and no-RA arthritides express memory markers and ZAP70 and characterize the aggregate pattern irrespectively of the autoantibody status. Mol Med 17:901–909